Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 165

1.

Outcomes in locally advanced rectal cancer with highly selective preoperative chemoradiotherapy.

Williamson JS, Jones HG, Davies M, Evans MD, Hatcher O, Beynon J, Harris DA; Swansea Colorectal Cancer Group.

Br J Surg. 2014 Sep;101(10):1290-8. doi: 10.1002/bjs.9570. Epub 2014 Jun 12.

PMID:
24924947
[PubMed - indexed for MEDLINE]
2.

Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.

Madbouly KM, Hussein AM, Abdelzaher E.

Am J Surg. 2014 Sep;208(3):332-41. doi: 10.1016/j.amjsurg.2013.10.023. Epub 2014 Jan 17.

PMID:
24581995
[PubMed - indexed for MEDLINE]
3.

Oncologic outcomes after radical surgery following preoperative chemoradiotherapy for locally advanced lower rectal cancer: abdominoperineal resection versus sphincter-preserving procedure.

Kim JS, Hur H, Kim NK, Kim YW, Cho SY, Kim JY, Min BS, Ahn JB, Keum KC, Kim H, Sohn SK, Cho CH.

Ann Surg Oncol. 2009 May;16(5):1266-73. doi: 10.1245/s10434-009-0338-3. Epub 2009 Feb 18.

PMID:
19224287
[PubMed - indexed for MEDLINE]
4.

Preoperative long course chemoirradiation in a developing country for rectal carcinoma: Kuala Lumpur hospital experience.

Lee WC, Yusof MM, Lau FN, Phua VC.

Asian Pac J Cancer Prev. 2013;14(6):3941-4.

PMID:
23886211
[PubMed - indexed for MEDLINE]
Free Article
5.

Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases.

Pacelli F, Sanchez AM, Covino M, Tortorelli AP, Bossola M, Valentini V, Gambacorta MA, Doglietto GB.

Am Surg. 2013 Feb;79(2):151-61.

PMID:
23336654
[PubMed - indexed for MEDLINE]
6.

Pre-operative chemoradiation for non-metastatic locally advanced rectal cancer.

McCarthy K, Pearson K, Fulton R, Hewitt J.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD008368. doi: 10.1002/14651858.CD008368.pub2. Review.

PMID:
23235660
[PubMed - indexed for MEDLINE]
7.

Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.

Tural D, Ozturk M, Selcukbiricik F, Yildiz O, Elicin O, Turna H, Guney S, Ozguroglu M.

J BUON. 2013 Apr-Jun;18(2):385-90.

PMID:
23818350
[PubMed - indexed for MEDLINE]
8.

Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.

Lim SB, Choi HS, Jeong SY, Kim DY, Jung KH, Hong YS, Chang HJ, Park JG.

Ann Surg. 2008 Aug;248(2):243-51. doi: 10.1097/SLA.0b013e31817fc2a0.

PMID:
18650634
[PubMed - indexed for MEDLINE]
9.

What is the significance of the circumferential margin in locally advanced rectal cancer after neoadjuvant chemoradiotherapy?

Trakarnsanga A, Gonen M, Shia J, Goodman KA, Nash GM, Temple LK, Guillem JG, Paty PB, Garcia-Aguilar J, Weiser MR.

Ann Surg Oncol. 2013 Apr;20(4):1179-84. doi: 10.1245/s10434-012-2722-7. Epub 2013 Jan 18.

PMID:
23328971
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Clinical implication of negative conversion of predicted circumferential resection margin status after preoperative chemoradiotherapy for locally advanced rectal cancer.

Lee NK, Kim CY, Park YJ, Yang DS, Yoon WS, Kim SH, Kim J.

Eur J Radiol. 2014 Feb;83(2):245-9. doi: 10.1016/j.ejrad.2013.10.029. Epub 2013 Nov 7.

PMID:
24268789
[PubMed - indexed for MEDLINE]
11.

Neoadjuvant treatment response as an early response indicator for patients with rectal cancer.

Park IJ, You YN, Agarwal A, Skibber JM, Rodriguez-Bigas MA, Eng C, Feig BW, Das P, Krishnan S, Crane CH, Hu CY, Chang GJ.

J Clin Oncol. 2012 May 20;30(15):1770-6. doi: 10.1200/JCO.2011.39.7901. Epub 2012 Apr 9.

PMID:
22493423
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Neoadjuvant-intensified treatment for rectal cancer: time to change?

Musio D, De Felice F, Bulzonetti N, Guarnaccia R, Caiazzo R, Bangrazi C, Raffetto N, Tombolini V.

World J Gastroenterol. 2013 May 28;19(20):3052-61. doi: 10.3748/wjg.v19.i20.3052.

PMID:
23716984
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Multicenter Evaluation of Rectal cancer ReImaging pOst Neoadjuvant (MERRION) Therapy.

Hanly AM, Ryan EM, Rogers AC, McNamara DA, Madoff RD, Winter DC; MERRION Study Group.

Ann Surg. 2014 Apr;259(4):723-7. doi: 10.1097/SLA.0b013e31828f6c91.

PMID:
23744576
[PubMed - indexed for MEDLINE]
14.

Routine defunctioning stoma after chemoradiation and total mesorectal excision: a single-surgeon experience.

Lin SC, Chen PC, Lee CT, Tsai HM, Lin PC, Chen HH, Wu YH, Lin BW, Su WP, Lee JC.

World J Gastroenterol. 2013 Mar 21;19(11):1797-804. doi: 10.3748/wjg.v19.i11.1797.

PMID:
23555168
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Analysis of clinical outcomes and prognostic factors of neoadjuvant chemoradiotherapy combined with surgery: intraperitoneal versus extraperitoneal rectal cancer.

Benzoni E, Terrosu G, Bresadola V, Cerato F, Cojutti A, Milan E, Dado G, Bresadola F.

Eur J Cancer Care (Engl). 2006 Jul;15(3):286-92.

PMID:
16882126
[PubMed - indexed for MEDLINE]
16.

Reappraisal of pretreatment carcinoembryonic antigen in patients with rectal cancer receiving preoperative chemoradiotherapy.

Yeo SG, Kim DY, Chang HJ, Park JW, Oh JH, Kim BC, Baek JY, Kim SY, Kim TH.

Tumori. 2013 Jan-Feb;99(1):93-9. doi: 10.1700/1248.13795.

PMID:
23549007
[PubMed - indexed for MEDLINE]
17.

Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.

Bosset JF, Calais G, Mineur L, Maingon P, Stojanovic-Rundic S, Bensadoun RJ, Bardet E, Beny A, Ollier JC, Bolla M, Marchal D, Van Laethem JL, Klein V, Giralt J, Clavère P, Glanzmann C, Cellier P, Collette L; EORTC Radiation Oncology Group.

Lancet Oncol. 2014 Feb;15(2):184-90. doi: 10.1016/S1470-2045(13)70599-0. Epub 2014 Jan 17.

PMID:
24440473
[PubMed - indexed for MEDLINE]
18.

Prognostic impact of circumferential resection margin in rectal cancer treated with preoperative chemoradiotherapy.

Hwang MR, Park JW, Park S, Yoon H, Kim DY, Chang HJ, Kim SY, Park SC, Choi HS, Oh JH, Jeong SY.

Ann Surg Oncol. 2014 Apr;21(4):1345-51. doi: 10.1245/s10434-014-3484-1. Epub 2014 Jan 28.

PMID:
24468928
[PubMed - indexed for MEDLINE]
19.

Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.

Shanmugan S, Arrangoiz R, Nitzkorski JR, Yu JQ, Li T, Cooper H, Konski A, Farma JM, Sigurdson ER.

Ann Surg Oncol. 2012 Jul;19(7):2178-85. doi: 10.1245/s10434-012-2248-z. Epub 2012 Mar 7.

PMID:
22395978
[PubMed - indexed for MEDLINE]
20.

Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?

Mawdsley S, Glynne-Jones R, Grainger J, Richman P, Makris A, Harrison M, Ashford R, Harrison RA, Osborne M, Livingstone JI, MacDonald P, Mitchell IC, Meyrick-Thomas J, Northover JM, Windsor A, Novell R, Wallace M.

Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):745-52.

PMID:
16199310
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk